Literature DB >> 25645925

MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1.

Hakim Bouamar1, Daifeng Jiang1, Long Wang1, An-Ping Lin1, Manoela Ortega1, Ricardo C T Aguiar2.   

Abstract

In biological processes, the balance between positive and negative inputs is critical for an effective physiological response and to prevent disease. A case in point is the germinal center (GC) reaction, wherein high mutational and proliferation rates are accompanied by an obligatory suppression of the DNA repair machinery. Understandably, when the GC reaction goes awry, loss of immune cells or lymphoid cancer ensues. Here, we detail the functional interactions that make microRNA 155 (miR-155) a key part of this process. Upon antigen exposure, miR-155(-/-) mature B cells displayed significantly higher double-strand DNA break (DSB) accumulation and p53 activation than their miR-155(+/+) counterparts. Using B cell-specific knockdown strategies, we confirmed the role of the miR-155 target Aicda (activation-induced cytidine deaminase) in this process and, in combination with a gain-of-function model, unveiled a previously unappreciated role for Socs1 in directly modulating p53 activity and the DNA damage response in B lymphocytes. Thus, miR-155 controls the outcome of the GC reaction by modulating its initiation (Aicda) and termination (Socs1/p53 response), suggesting a mechanism to explain the quantitative defect in germinal center B cells found in mice lacking or overexpressing this miRNA.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645925      PMCID: PMC4372698          DOI: 10.1128/MCB.01446-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Widespread changes in protein synthesis induced by microRNAs.

Authors:  Matthias Selbach; Björn Schwanhäusser; Nadine Thierfelder; Zhuo Fang; Raya Khanin; Nikolaus Rajewsky
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

2.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.

Authors:  Grace Teng; Paul Hakimpour; Pablo Landgraf; Amanda Rice; Thomas Tuschl; Rafael Casellas; F Nina Papavasiliou
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

3.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

4.  Inositol phosphatase SHIP1 is a primary target of miR-155.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

5.  Mutation in TET2 in myeloid cancers.

Authors:  François Delhommeau; Sabrina Dupont; Véronique Della Valle; Chloé James; Severine Trannoy; Aline Massé; Olivier Kosmider; Jean-Pierre Le Couedic; Fabienne Robert; Antonio Alberdi; Yann Lécluse; Isabelle Plo; François J Dreyfus; Christophe Marzac; Nicole Casadevall; Catherine Lacombe; Serge P Romana; Philippe Dessen; Jean Soulier; Franck Viguié; Michaela Fontenay; William Vainchenker; Olivier A Bernard
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

6.  Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.

Authors:  Anja Mottok; Christoph Renné; Marc Seifert; Elsie Oppermann; Wolf Bechstein; Martin-Leo Hansmann; Ralf Küppers; Andreas Bräuninger
Journal:  Blood       Date:  2009-09-04       Impact factor: 22.113

7.  Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

Authors:  Ken H Young; Karen Leroy; Michael B Møller; Gisele W B Colleoni; Margarita Sánchez-Beato; Fábio R Kerbauy; Corinne Haioun; Jens C Eickhoff; Allen H Young; Philippe Gaulard; Miguel A Piris; Terry D Oberley; William M Rehrauer; Brad S Kahl; James S Malter; Elias Campo; Jan Delabie; Randy D Gascoyne; Andreas Rosenwald; Lisa Rimsza; James Huang; Rita M Braziel; Elaine S Jaffe; Wyndham H Wilson; Louis M Staudt; Julie M Vose; Wing C Chan; Dennis D Weisenburger; Timothy C Greiner
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

8.  Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein.

Authors:  Li-Fan Lu; To-Ha Thai; Dinis Pedro Calado; Ashutosh Chaudhry; Masato Kubo; Kentaro Tanaka; Gabriel B Loeb; Hana Lee; Akihiko Yoshimura; Klaus Rajewsky; Alexander Y Rudensky
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

9.  MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation.

Authors:  Yair Dorsett; Kevin M McBride; Mila Jankovic; Anna Gazumyan; To-Ha Thai; Davide F Robbiani; Michela Di Virgilio; Bernardo Reina San-Martin; Gordon Heidkamp; Tanja A Schwickert; Thomas Eisenreich; Klaus Rajewsky; Michel C Nussenzweig
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

Review 10.  Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin.

Authors:  Andrea Kinner; Wenqi Wu; Christian Staudt; George Iliakis
Journal:  Nucleic Acids Res       Date:  2008-09-04       Impact factor: 16.971

View more
  19 in total

Review 1.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

2.  MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome.

Authors:  ZhiJun Qiu; An-Ping Lin; Shoulei Jiang; Sara M Elkashef; Jamie Myers; Subramanya Srikantan; Binu Sasi; John Z Cao; Lucy A Godley; Dinesh Rakheja; Yingli Lyu; Siyuan Zheng; Muniswamy Madesh; Yuzuru Shiio; Patricia L M Dahia; Ricardo C T Aguiar
Journal:  Cell Chem Biol       Date:  2020-02-25       Impact factor: 8.116

3.  Generation and characterization of the Eµ-Irf8 mouse model.

Authors:  Zhijun Qiu; Kenneth N Holder; An-Ping Lin; Jamie Myers; Shoulei Jiang; Karla M Gorena; Marsha C Kinney; Ricardo C T Aguiar
Journal:  Cancer Genet       Date:  2020-06-03

4.  BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.

Authors:  Rosemary E Morman; Patrick G Schweickert; Stephen F Konieczny; Elizabeth J Taparowsky
Journal:  Eur J Immunol       Date:  2018-06-26       Impact factor: 5.532

Review 5.  The p53 Transcriptional Network Influences Microglia Behavior and Neuroinflammation.

Authors:  Macarena S Aloi; Wei Su; Gwenn A Garden
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

6.  SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes.

Authors:  Emmanuelle Saint-Germain; Lian Mignacca; Mathieu Vernier; Diwakar Bobbala; Subburaj Ilangumaran; Gerardo Ferbeyre
Journal:  Aging (Albany NY)       Date:  2017-10-28       Impact factor: 5.682

7.  Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells.

Authors:  Francesca Grespi; Vivien Landré; Alina Molchadsky; Nicola Di Daniele; Luigi Tonino Marsella; Gerry Melino; Varda Rotter
Journal:  Cell Death Dis       Date:  2016-12-29       Impact factor: 8.469

Review 8.  miRNA-Mediated Control of B Cell Responses in Immunity and SLE.

Authors:  Stephanie L Schell; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

9.  A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.

Authors:  Long Wang; Kenneth N Holder; Avvaru N Suhasini; An-Ping Lin; Harshita Bhatnagar; Sang-Woo Kim; August W Moritz; Ricardo C T Aguiar
Journal:  Leukemia       Date:  2015-10-27       Impact factor: 11.528

10.  Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.

Authors:  Izabella Slezak-Prochazka; Joost Kluiver; Debora de Jong; Katarzyna Smigielska-Czepiel; Gertrud Kortman; Melanie Winkle; Bea Rutgers; Jasper Koerts; Lydia Visser; Arjan Diepstra; Bart-Jan Kroesen; Anke van den Berg
Journal:  Oncotarget       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.